How long does it take for amitriptyline (tricyclic antidepressant) to wash out of the system after the last dose?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Amitriptyline Washout Period

Amitriptyline requires approximately 3.5 to 4 days (85-96 hours) to wash out after the last dose, based on its elimination half-life of approximately 17 hours and the standard pharmacokinetic principle that 5 half-lives are needed for >97% drug elimination.

Pharmacokinetic Basis for Washout

The washout period is calculated using amitriptyline's elimination half-life:

  • Amitriptyline has a biological half-life of approximately 17 hours when administered intravenously, which represents the most accurate pharmacokinetic measurement 1
  • Complete drug elimination requires at least 5 half-lives, as established by consensus guidelines for therapeutic drug monitoring 2
  • This translates to 85 hours (approximately 3.5 days) for amitriptyline to be essentially eliminated from the system 1

Metabolism and Active Metabolites

The washout calculation becomes more complex when considering active metabolites:

  • Amitriptyline is rapidly metabolized to nortriptyline, its active metabolite, primarily through N-demethylation 3, 4
  • Nortriptyline formation occurs rapidly, with 30-67% produced during first-pass metabolism through the liver 4
  • The total amount of nortriptyline entering systemic circulation is approximately one-quarter of the amitriptyline dose 4
  • Virtually the entire dose is excreted as glucuronide or sulfate conjugates of metabolites within 24 hours, with little unchanged drug appearing in urine 3

Clinical Washout Period Recommendation

For practical clinical purposes, allow 1 week (7 days) for complete washout to account for:

  • Individual pharmacokinetic variability 2
  • The presence of active metabolite nortriptyline 4
  • Genetic polymorphisms in CYP2D6 metabolism that can significantly affect elimination rates 2
  • Potential drug interactions that may prolong elimination 5

Important Clinical Considerations

Factors That Prolong Washout

  • Hepatic insufficiency significantly affects elimination since amitriptyline undergoes extensive hepatic metabolism 2
  • CYP2D6 poor metabolizers (5-8% of Caucasians) may have substantially prolonged elimination 2
  • Recent use of CYP2D6 inhibitors can dramatically extend washout periods—terbinafine, for example, can cause clinically significant interactions for at least 3 months after discontinuation 5
  • Chronic use with high doses may require longer washout periods due to tissue accumulation 6, 7

Withdrawal Phenomena vs. Washout

  • Withdrawal symptoms can occur within the first 2 weeks of discontinuation, consisting of irritability, dream and sleep disturbance, and restlessness 6, 7
  • These withdrawal symptoms are distinct from pharmacokinetic washout and represent neuroadaptive changes rather than drug presence 7
  • Withdrawal reactions should not be confused with incomplete drug elimination when timing subsequent interventions 7

Practical Algorithm for Clinical Decision-Making

Standard patients (normal hepatic function, no CYP2D6 inhibitors):

  • Wait 7 days for complete washout 2, 1

Patients with hepatic impairment:

  • Wait 10-14 days minimum 2

Patients recently on CYP2D6 inhibitors (e.g., terbinafine, fluoxetine, paroxetine):

  • Wait at least 3 months if terbinafine was used 5
  • Consider therapeutic drug monitoring if timing is critical 2

Patients with unknown CYP2D6 status and concerning symptoms:

  • Consider genotyping or phenotyping if rapid medication changes are needed 2
  • Therapeutic drug monitoring can confirm drug clearance 2

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.